Alessandra Longobardi

Via Sergio Pansini 5
Naples, 80131, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Strengths and pitfalls of NNT and NNH in early breast cancer escalation trials.

Strengths and pitfalls of NNT and NNH in early breast cancer escalation trials.

Journal: Breast (Edinburgh, Scotland)

Published: March 19, 2026

Central nervous system and leptomeningeal metastases in patients with HER2-positive breast cancer: A comprehensive review and therapeutic algorithm proposal.

Central nervous system and leptomeningeal metastases in patients with HER2-positive breast cancer: A comprehensive review and therapeutic algorithm proposal.

Journal: Cancer treatment reviews

Published: March 12, 2026

Analysis of Large Language Model Decision Making in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer.

Analysis of Large Language Model Decision Making in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer.

Journal: JCO clinical cancer informatics

Published: March 06, 2026

Impact of trop-2 expression on the efficacy of trop-2-targeted antibody-drug conjugates in metastatic breast cancer: a systematic review and meta-analysis.

Impact of trop-2 expression on the efficacy of trop-2-targeted antibody-drug conjugates in metastatic breast cancer: a systematic review and meta-analysis.

Journal: Journal of the National Cancer Institute

Published: February 17, 2026

Association of neoadjuvant chemotherapy dose intensity with pathological complete response and event-free survival in HER2-negative early breast cancer.

Association of neoadjuvant chemotherapy dose intensity with pathological complete response and event-free survival in HER2-negative early breast cancer.

Journal: European journal of cancer (Oxford, England : 1990)

Published: August 20, 2025

Efficacy and safety of systemic therapies following progression on CDK4/6 inhibitors in patients with HR+/HER2- metastatic breast cancer: a systematic review and network meta-analysis.

Efficacy and safety of systemic therapies following progression on CDK4/6 inhibitors in patients with HR+/HER2- metastatic breast cancer: a systematic review and network meta-analysis.

Journal: EClinicalMedicine

Published: July 15, 2025

Influence of ethnicity on cyclin-dependent kinase inhibitor efficacy and toxicity: A systematic review and meta-analysis.

Influence of ethnicity on cyclin-dependent kinase inhibitor efficacy and toxicity: A systematic review and meta-analysis.

Journal: Breast (Edinburgh, Scotland)

Published: September 25, 2024

Efficacy of PARP inhibitors in advanced high-grade serous ovarian cancer according to BRCA domain mutations and mutation type.

Efficacy of PARP inhibitors in advanced high-grade serous ovarian cancer according to BRCA domain mutations and mutation type.

Journal: Frontiers in oncology

Published: April 05, 2024

Evaluation of long-term effects in patients treated with Fränkel-2 appliance.

Evaluation of long-term effects in patients treated with Fränkel-2 appliance.

Journal: European journal of paediatric dentistry

Published: December 22, 2011

Showing 1-9 of 9

Last Updated: 09/26/2026